Precision Neuroscience

United States
Troy, New Hampshire, United States, 10010

Company profile

Precision Neuroscience company profile

Precision Neuroscience is a neural platform for next-generation brain-computer interface technology. The company's goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. Its brain–computer interface is designed to be minimally invasive, safely removable, and capable of processing large amounts of data. The company was founded in 2021 and is based in New York.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Founded
2021-05-01, Month

Headquarters

Postal code
10010
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
4
Total equity funding
$155M
Last funding
Series Unknown / 2025-11-05
Last equity funding
Series Unknown
Investors
16
Lead investors
6
Founders
4
Articles
114

Founders and investors

Founders

Benjamin RapoportDemetrios PapageorgiouMark HettickMichael Mager

Lead investors

Alumni VenturesB CapitalForepont Capital PartnersGeneral Equity HoldingsSCI VenturesSteadview Capital

Investors

Alumni VenturesB CapitalDraper AssociatesMubadala CapitalSoleus Capital